Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 1, 2003

View Archived Issues

New drug with potential in the management of preterm uterine activity

Tacrolimus could improve liver function after liver transplantation

Bezafibrate diminishes insulin resistance and improves lipid metabolism in hypertriglyceridemia

LY-333531 reduces diabetic hyperalgesia

KF-24345: an adenosine uptake inhibitor with antiinflammatory properties

Roxithromycin has antiallergic activity

Lilly presents new melanocortin MC4 agonists in a recent patent

BMS scientists prepare novel HIV reverse transcriptase inhibitors

FDA approval for Gamunex

Pharmacia patent covers novel oxazolidinone-based antibacterial agents

Potent and selective CDK4 inhibitors identified by Warner-Lambert researchers

Dainippon licenses AC-3933 to Aventis

Novel HCV NS3 protease inhibitors in early development at Schering-Plough

SCRAS describes dual lipid peroxidation inhibitors/sodium channel modulators and their use

New dosage strengths approved for Avandamet

NICE recommends first-line treatment with Glivec for newly diagnosed CML patients

Schering AG plans phase III Crohn's disease study of Leukine

Syn X Pharma finalizes Alzheimer's agreement with Ortho-Clinical Diagnostics

Phase I study evaluates new breast cancer detection method

Enrollment commences in phase I trial of Dacogen plus Proleukin for cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...